A Study of Nilotinib in Growing Vestibular Schwannomas

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2013

Conditions
Growing Vestibular Schwannomas
Interventions
DRUG

Nilotinib

Trial Locations (2)

m5t 2s8

Toronto Western Hospital, Toronto

University Health Network, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Health Network, Toronto

OTHER